•
Sep 30, 2022
Akoya Q3 2022 Earnings Report
Akoya reported record revenue with 40% YoY growth.
Key Takeaways
Akoya Biosciences reported a record revenue of $18.9 million for Q3 2022, a 40% increase compared to the previous year. The company also raised its full-year 2022 revenue guidance to $73-75 million.
Total revenue reached $18.9 million, a 40% increase year-over-year.
Product revenue increased by 32% to $14.4 million.
Services and other revenue increased by 69% to $4.4 million.
55 instruments were sold, a 67% increase compared to the prior year period.
Akoya
Akoya
Akoya Revenue by Segment
Forward Guidance
The company is raising its full year 2022 revenue guidance range to $73-75 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income